|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
|
 |
| |
|
|
|
|
Industry Insight
Robert Harris, PMPS Industry Advisor, highlights the importance of patient-centricity and picks out key articles from this issue that address this topic.
|
|
|
|
|
mHealth and Smart Technology
Breathing New Life into Asthma Care
Ali Moiyed at Aerobit Health uncovers how connected devices could enhance patient compliance. With a particular focus on inhalers, he argues that this could be one way in which the pharma industry can keep up with advances in technology.
|
|
|
Optimising Inhalation Therapy
Partial to Particles
Breath-actuated mechanisms are becoming increasingly common in inhalation devices due to their beneficial impact on fine particle doses. Dr David Lewis, Alan Tweedie and Francesca Mason at Chiesi investigate their potential.
|
|
|
|
The Falsified Medicines Directive
Is Europe Ready?
As the Falsified Medicines Directive deadline looms ever closer, Christoph Krähenbühl at 3C Excellis Europe clarifies what everyone, from manufacturers to wholesalers and pharmacists, need to do to ensure that the continent is prepared.
|
|
|
|
Electronic Batch Records
Paper Chase
COPA-DATA’s Robert Harrison argues for the transition from paper-based documentation to digitised production records in a bid to improve regulatory compliance and the management of data.
|
|
|
|
Outsourcing Supply Chains
Branching Out
Developing robust supply chains while simultaneously reducing expenditure and meeting global compliance can be challenging. Henry Moran and Amy Shortman of ASC Associates share their thoughts on why turning to outsourcing could be the answer.
|
|
|
Anti-Counterfeiting Measures
Security Breach
As a result of increased globalisation, pharma firms are constantly being put under greater pressure to provide a secure end-to-end supply chain. Although a daunting challenge, Pinkerton’s Steve Ward explains how this can be achieved to ensure drug safety and mitigate the risk of large economic losses.
|
|
|
Innovative Supply Chains
New Thinking
Jan Denecker at UPS Europe discusses the significance of flexibility in the supply chain as a result of today’s shift towards increasingly complex drugs. Manufacturers and third-party logistics providers must be ready to work together to create the efficiency needed.
|
|
|
|
Advancing Patient Protection
Easy Access
Amcor’s Colin Reed and Greg Rosati investigate the vital role that packaging plays in compliance. Often seen as an inconvenient part of the supply chain, they uncover why it should be treated as more than simply fulfilling a regulatory need.
|
|
|
Child-Resistant Packaging
Open and Close
In order to develop child-resistant packaging that is also easy to use for the elderly, continuous testing is key. Stephen Wilkins at Davies Development and Testing sheds some light on the complications with regards to staying compliant.
|
|
|
Packaging Design
First Impression
Conveying important information to patients through packaging and labelling is an arduous task in the pharma industry. Essentra’s Alan Davies explains why getting it right is so important in terms of design and compliance.
|
|
|
Patient-Centred Design
Packaging for People
Dr Karel van der Waarde at Graphic Design-Research elucidates why it is necessary to consider the end user as well as legal and economic packaging requirements so that medicines can be handled safely, correctly and efficiently.
|
|
|
|
Event Preview
Join the Crowd
Valerio Del Vecchio at the PPMA Group presents an enticing look at the upcoming PPMA Show and why Birmingham is the place to be this September.
|
|
|
|
|
End of the Line
Manufacturing a Renaissance
Pharma keeps on innovating, but PMPS Industry Advisor Robert Harris asks if this is enough for the sector to stay on par with other areas.
|
|
|
|
Clinical Supply Challenges
Under Control
The manufacture and distribution of controlled drugs is tightly governed, but regulations vary around the world and tend to cause a considerable amount of complexity. PCI Clinical Services’ Rich Nelson explores why experienced supply partners are vital in this field.
|
|
|
Clinical Trial Supply
Supply and Demand
SIRO Clinpharm’s Partha Chatterjee investigates the importance of collaboration between clinical operations and clinical trial supply teams in order to achieve more effective and efficient studies.
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Dempsey Demystifies Regulatory Cycle at DIA Europe
March 22, 2018 (Hartford, Conn.) – RWS Life Sciences Managing Director,
Sheena Dempsey, will present “Demystifying the Multilingual Complexities
in the Regulatory Cycle” at DIA Europe 2018, on April 17, at 3:30PM
(CET), in Basel, Switzerland.
More info >> |
|
 |
White Papers |
 |
|
Driving ROI: The Case for Investing in Contract & Site Regulatory Document Management Services
DrugDev
With tight timelines and complicated regulatory documentation requirements, getting a clinical trial up and running quickly is easier said than done. Key milestones can be achieved only after the successful negotiation of clinical trial agreements and completion of essential regulatory documents. Many clinical trials are hindered by inefficient, labor-intensive processes. Prolonged, inefficient activation can hamper investigator satisfaction and, ultimately, have a negative bottom-line impact for sponsors and CROs. In addition, the Sunshine Act is heightening the importance of financial disclosure in clinical trials. Without a robust financial disclosure strategy, sponsors cannot ensure that physician self-reported financial disclosure data are aligned with the payment data being reported through the Sunshine Act, increasing financial and regulatory risk.
More info >> |
|
 |
Industry Events |
 |
T3: Trials, Tech and Transformation
30-31 May 2018, Raleigh Convention Center, Raleigh, NC
T3
is back for 2018 to provide you with the latest updates and top tips from
across the clinical trials landscape. Connecting leading experts, influencers and innovators from pharma,
biotech, CROs, patient advocacy groups, academia and beyond, T3 is themeeting place for all stakeholders to
voice their questions, connect with peers, and get direct feedback from an
expert speaker line-up.And this
year, we're in Raleigh.
More info >> |
|
|
